NEOVACS
Biotech Therapeutic Vaccine Development
- B2B
About NEOVACS
Development of therapeutic vaccines targeting autoimmune and inflammatory diseases, alongside investments in innovative biotech and medtech companies.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Suresnes, Île-de-France, France
- Revenue
- $5.9M – $46.6MTamtam estimate
- Website
- neovacs.com
- linkedin.com/company/neovacs-sa
NEOVACS at a glance
NEOVACS is a B2B company in the Biotechnology Research industry, headquartered in Suresnes, Île-de-France, France.
NEOVACS has 11–50 employees.
NEOVACS's revenue is $5.9M – $46.6M (Tamtam estimate).
Selling to companies like NEOVACS?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies